COMBINATION THERAPY OF VEDOLIZUMAB AND A TNF ANTAGONIST IN IBD PATIENTS WITH SEVERE CHRONIC ACTIVE, THERAPY REFRACTORY DISEASE COURSE

被引：1
|
作者：
Kuehbacher, Tanja
AbuHashem, Raed
Langel, Natalie
Schreiber, Stefan
Drvarov, Oliver
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31568-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1933
引用
收藏
页码：S398 / S398
页数：1
相关论文
共 50 条
  • [1] Combination therapy of vedolizumab and a TNF antagonist in IBD patients with severe chronic active, therapy refractory disease course
    Kuehbacher, T.
    Abu Hashem, R.
    Langel, N.
    Schreiber, S.
    Drvarov, O.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S357 - S357
  • [2] COMBINATION THERAPY OF VEDOLIZUMAB AND TOFACITINIB IN IBD PATIENTS WITH CHRONIC ACTIVE REFRACTORY DISEASE COURSE AND SPONDYLARTHRITIS
    Kuehbacher, Tanja
    Leick, Angele
    Vongogh, Gwendolyn
    Porthun, Markus
    Schreiber, Stefan
    Cederqvist, Marco
    GASTROENTEROLOGY, 2019, 156 (06) : S881 - S881
  • [3] Efficacy of Vedolizumab As Induction Therapy in Refractory IBD Patients Following Multiple Anti-TNF Therapy Failures
    Stevens, Betsy W.
    Shelton, Edward
    Sauk, Jenny
    Khalili, Hamed
    Nguyen, Deanna D.
    White-Guthro, Margaret
    Bates, Mary Lou
    Giallourakis, Cosmas
    Garber, John
    Ananthakrishnan, Ashwin N.
    Yajnik, Vijay
    GASTROENTEROLOGY, 2015, 148 (04) : S869 - S869
  • [4] Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort
    Shelton, Edward
    Allegretti, Jessica R.
    Stevens, Betsy
    Lucci, Matthew
    Khalili, Hamed
    Nguyen, Deanna D.
    Sauk, Jenny
    Giallourakis, Cosmas
    Garber, John
    Hamilton, Matthew J.
    Tomczak, Michal
    Makrauer, Fredrick
    Burakoff, Robert B.
    Levine, Jonathan
    de Silva, Punyaganie
    Friedman, Sonia
    Ananthakrishnan, Ashwin
    Korzenik, Joshua R.
    Yajnik, Vijay
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (12) : 2879 - 2885
  • [5] Efficacy of vedolizumab as induction therapy in refractory IBD patients: a multicentre cohort
    Shelton, E.
    Allegretti, J.
    Stevens, B.
    Lucci, M.
    Ananthakrishnan, A.
    Yajnik, V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 138 - 139
  • [6] EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH CHRONIC ACTIVE POUCHITIS REFRACTORY TO ANTI-TNF THERAPY: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY
    Sallette, Morgane
    Bouhnik, Yoram
    Nachury, Maria
    Bellanger, Christophe
    Laharie, David
    Amiot, Aurelien
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    Altwegg, Romain
    Buisson, Anthony
    Reenaers, Catherine
    Bouguen, Guillaume
    Bourreille, Arnaud
    Gilletta, Cyrielle
    Serrero, Melanie
    Vuitton, Lucine
    Hebuterne, Xavier
    Filippi, Jerome
    GASTROENTEROLOGY, 2022, 162 (07) : S822 - S822
  • [7] Efficacy and safety of vedolizumab in patients with chronic active pouchitis refractory to anti-TNF therapy: Results of a retrospective multicenter study
    Sallette, M.
    Bouhnik, Y.
    Nachury, M.
    Bellanger, C.
    Laharie, D.
    Amiot, A.
    Peyrin-Biroulet, L.
    Roblin, X.
    Altwegg, R.
    Buisson, A.
    Reenaers, C.
    Bouguen, G.
    Vuitton, L.
    Bourreille, A.
    Gilletta, C.
    Serrero, M.
    Hebuterne, X.
    Filippi, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I084 - I085
  • [8] TNFα antagonist therapy in patients with joint disease and chronic viral infection
    Wendling, Daniel
    Herbein, Georges
    JOINT BONE SPINE, 2007, 74 (05) : 407 - 409
  • [9] Functional Molecular Network Analysis Enables Prediction of Response to Vedolizumab Therapy in Anti-TNF Refractory IBD Patients
    Breidert, Matthias
    Eftekhari, Pierre
    Louis, Francois
    Rotoiu, Claudia
    Rath, Timo
    Neurath, Markus F.
    Atreya, Raja
    CROHNS & COLITIS 360, 2020, 2 (02)
  • [10] Effectiveness of Vedolizumab Induction Therapy in IBD Patients
    Kaymak, Tanay
    Niess, Jan H.
    Hruz, Petr
    SWISS MEDICAL WEEKLY, 2017, 147 : 16S - 16S
12345